USP11 was originally identified by Valle and colleagues [3] and because of its role in a plethora of cellular processes, including DNA damage response [4–6], modulation of cellular senescence [7] and intracellular signaling [8–11], USP11 is an interesting target for cancer therapy. The gene discussed is USP11; the disease is cancer.